|
KMID : 1038620180360030200
|
|
Radiation Oncology Journal
2018 Volume.36 No. 3 p.200 ~ p.209
|
|
|
Effectiveness and feasibility of concurrent chemoradiotherapy using simultaneous integrated boostintensity modulated radiotherapy with and without induction chemotherapy for locally advanced pancreatic cancer
|
|
Oh Eun-Sang
Kim Tae-Hyun
Woo Sang-Myung
Lee Woo-Jin
Lee Ju-Hee
Youn Sang-Hee
Han Sung-Sik
Park Sang-Jae
Kim Dae-Yong
|
|
|
Abstract
|
|
|
Purpose: To evaluate the effectiveness and feasibility of chemoradiotherapy (CRT) using simultaneous integrated boost-intensity modulated radiotherapy (SIB-IMRT) in locally advanced pancreatic cancer (LAPC) patients.
Materials and Methods: Between January 2011 and May 2015, 47 LAPC patients received CRT using SIB-IMRT. Prior to SIBIMRT, 37 patients (78.7%) received induction chemotherapy (IC-CRT group) and remaining 10 patients (21.3%) did not received induction chemotherapy (CRT group). During SIB-IMRT, all patients received concomitant chemotherapy, with gemcitabine (n = 37) and capecitabine (n = 10).
Results: At the time of analysis, 45 patients had died and 2 patients remained alive and the median follow-up time was 14.2 months (range, 3.3 to 51.4 months). For all patients, the median times of local progression-free survival (LPFS), progression-free survival (PFS), and overall survival (OS) were 18.1, 10.3, and 14.2 months, respectively. The median time of LPFS between IC-CRT and CRT groups was similar (18.1 months vs. 18.3 months, p = 0.711). IC-CRT group had a higher trend in PFS (10.9 months vs. 4.1 months, p = 0.054) and had significantly higher OS (15.4 months vs. 9.5 months, p = 0.007) than CRT group. In multivariate analysis, the use of induction chemotherapy and tumor response were significant factors associated with OS (p < 0.05, each). During SIBIMRT, toxicity of grade ≥3 was observed in 7 patients (14.9%) in all patients.
Conclusions: CRT using SIB-IMRT is feasible and promising in LAPC patients.
|
|
|
KEYWORD
|
|
|
Pancreas neoplasms, Radiotherapy, Intensity-modulated radiotherapy, Survival
|
|
|
FullTexts / Linksout information
|
|
|
|
|
|
Listed journal information
|
|
  
|
|